SCOTIA CAPITAL INC. - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 135 filers reported holding XENON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 10.04 and the average weighting 0.4%.

Quarter-by-quarter ownership
SCOTIA CAPITAL INC. ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$1,059,087
-14.3%
26,859
-21.6%
0.01%
-20.0%
Q3 2022$1,236,000
+8.4%
34,251
-8.6%
0.01%
+25.0%
Q2 2022$1,140,000
+9.0%
37,474
+9.5%
0.01%
+14.3%
Q1 2022$1,046,000
-0.7%
34,216
+1.5%
0.01%0.0%
Q4 2021$1,053,000
+85.7%
33,696
-9.3%
0.01%
+75.0%
Q3 2021$567,000
-23.9%
37,136
-7.2%
0.00%
-20.0%
Q2 2021$745,000
+1.2%
40,017
-2.7%
0.01%
-16.7%
Q1 2021$736,000
+17.0%
41,137
+0.6%
0.01%0.0%
Q4 2020$629,000
+36.1%
40,897
-2.0%
0.01%
+20.0%
Q3 2020$462,000
-11.5%
41,734
+0.4%
0.01%
-28.6%
Q2 2020$522,000
+10.8%
41,567
+0.1%
0.01%0.0%
Q1 2020$471,000
-42.6%
41,546
-33.5%
0.01%
-22.2%
Q4 2019$820,000
+37.4%
62,509
-5.7%
0.01%
+28.6%
Q3 2019$597,000
-9.5%
66,308
-0.9%
0.01%
-12.5%
Q2 2019$660,000
-3.2%
66,937
-0.2%
0.01%
-11.1%
Q1 2019$682,000
+62.0%
67,082
+0.6%
0.01%
+50.0%
Q4 2018$421,000
-44.2%
66,704
+16.8%
0.01%
-40.0%
Q3 2018$754,000
+140.1%
57,086
-11.3%
0.01%
+150.0%
Q2 2018$314,000
-0.3%
64,3570.0%0.00%0.0%
Q1 2018$315,000
+77.0%
64,357
+2.3%
0.00%
+100.0%
Q4 2017$178,000
+11.2%
62,918
+15.7%
0.00%0.0%
Q3 2017$160,000
+42.9%
54,371
+52.6%
0.00%0.0%
Q2 2017$112,000
+6.7%
35,629
+36.0%
0.00%0.0%
Q1 2017$105,000
-34.4%
26,203
+25.9%
0.00%
-33.3%
Q4 2016$160,000
-5.3%
20,818
-0.0%
0.00%0.0%
Q3 2016$169,00020,8200.00%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 850,000$15,215,0003.58%
ACUTA CAPITAL PARTNERS, LLC 412,500$7,384,0002.66%
BVF INC/IL 3,481,778$62,324,0002.34%
Soleus Capital Management, L.P. 708,117$12,675,0002.28%
COMMODORE CAPITAL LP 301,392$5,395,0002.15%
DAFNA Capital Management LLC 406,535$7,277,0001.73%
Parkman Healthcare Partners LLC 374,395$6,702,0001.56%
Avoro Capital Advisors LLC 3,650,000$65,335,0001.13%
KNOTT DAVID M 144,101$2,579,0001.10%
Orbimed Advisors 2,497,917$44,713,0000.42%
View complete list of XENON PHARMACEUTICALS INC shareholders